51 – 60 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
- Contribution to journal › Letter
-
Mark
Clinical and daily respiratory care and clinical trials within the COVID-19 era
- Contribution to journal › Debate/Note/Editorial
-
Mark
The need for clean air : The way air pollution and climate change affect allergic rhinitis and asthma
- Contribution to journal › Scientific review
-
Mark
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
- Contribution to journal › Article
-
Mark
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
- Contribution to journal › Scientific review
- 2019
-
Mark
Targeting lipid mediators in asthma : time for reappraisal
- Contribution to journal › Article
-
Mark
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases : An EAACI Taskforce on Immunopharmacology position paper
- Contribution to journal › Article
-
Mark
Much ado about Biologicals : Highlights of the Master Class on Biologicals, Prague, 2018
- Contribution to journal › Letter
-
Mark
Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
- Contribution to journal › Article
-
Mark
The potential role of CD16highCD62Ldim neutrophils in the allergic asthma
- Contribution to journal › Letter